Indeed, two variants were demonstrated to exhibit increased transactivation activity.11 Here, biallelic RAX2 variants underlie an RP phenotype, expected to lead to loss of function, due to the absence of protein synthesis or the disruption of functional domains. The gene discussed is RAX2; the disease is retinitis pigmentosa 1.